You are here

Study Of Sunitinib Malate Versus Sorafenib In Patients With Inoperable Liver Cancer

Last updated on February 20, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Fountain Valley, California, 92708 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Hepatocellular Carcinoma
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Histologically-confirmed diagnosis of hepatocellular carcinoma

- presence of measurable disease by radiographic imaging

- Child-Pugh class A

- ECOG PS 0 or 1

- adequate organ function.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Prior treatment with any systemic treatment for hepatocellular carcinoma

- prior local treatment within 4 weeks from entry

- presence of clinically relevant ascites

- severe hemorrhage

- known HIV or serious acute or chronic illness

- current treatment on another clinical trial

- pregnancy or breastfeeding

NCT00699374
Pfizer
Terminated
Study Of Sunitinib Malate Versus Sorafenib In Patients With Inoperable Liver Cancer

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Hepatocellular Carcinoma
NCT01210495
All Genders
18+
Years
Multiple Sites
Liver Neoplasms, Unresectable Hepatocellular Carcinoma
NCT00247676
All Genders
18+
Years
Multiple Sites
Renal Cell Carcinoma, Glioblastoma, Hepatocellular Carcinoma
NCT01441388
All Genders

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now